PL2029583T3 - Nowe pochodne benzotiazynonu i ich zastosowanie jako środków przeciwbakteryjnych - Google Patents
Nowe pochodne benzotiazynonu i ich zastosowanie jako środków przeciwbakteryjnychInfo
- Publication number
- PL2029583T3 PL2029583T3 PL06743049T PL06743049T PL2029583T3 PL 2029583 T3 PL2029583 T3 PL 2029583T3 PL 06743049 T PL06743049 T PL 06743049T PL 06743049 T PL06743049 T PL 06743049T PL 2029583 T3 PL2029583 T3 PL 2029583T3
- Authority
- PL
- Poland
- Prior art keywords
- antibacterial agents
- new
- benzothiazinone derivatives
- derivatives
- new benzothiazinone
- Prior art date
Links
- MJNPHLBKHKJDEF-UHFFFAOYSA-N 2h-1$l^{4},2-benzothiazine 1-oxide Chemical class C1=CC=C2S(=O)NC=CC2=C1 MJNPHLBKHKJDEF-UHFFFAOYSA-N 0.000 title 1
- 239000003242 anti bacterial agent Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/113—Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06743049A EP2029583B1 (en) | 2006-05-24 | 2006-05-24 | New benzothiazinone derivatives and their use as antibacterial agents |
| PCT/EP2006/004942 WO2007134625A1 (en) | 2006-05-24 | 2006-05-24 | New benzothiazinone derivatives and their use as antibacterial agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2029583T3 true PL2029583T3 (pl) | 2010-10-29 |
Family
ID=37595033
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06743049T PL2029583T3 (pl) | 2006-05-24 | 2006-05-24 | Nowe pochodne benzotiazynonu i ich zastosowanie jako środków przeciwbakteryjnych |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US7863268B2 (pl) |
| EP (1) | EP2029583B1 (pl) |
| JP (1) | JP5068813B2 (pl) |
| KR (1) | KR101314999B1 (pl) |
| CN (1) | CN101472922B (pl) |
| AP (1) | AP2444A (pl) |
| AT (1) | ATE470667T1 (pl) |
| AU (1) | AU2006343832B2 (pl) |
| BR (1) | BRPI0621693B8 (pl) |
| CA (1) | CA2652841C (pl) |
| CR (1) | CR10519A (pl) |
| CY (1) | CY1110769T1 (pl) |
| DE (1) | DE602006014885D1 (pl) |
| DK (1) | DK2029583T3 (pl) |
| EA (1) | EA015910B1 (pl) |
| ES (1) | ES2345902T3 (pl) |
| IL (1) | IL195453A (pl) |
| MX (1) | MX2008014958A (pl) |
| NZ (1) | NZ573833A (pl) |
| PL (1) | PL2029583T3 (pl) |
| PT (1) | PT2029583E (pl) |
| SI (1) | SI2029583T1 (pl) |
| TN (1) | TNSN08474A1 (pl) |
| WO (1) | WO2007134625A1 (pl) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2029583T3 (pl) | 2006-05-24 | 2010-10-29 | Leibniz Inst Fuer Naturstoff Forschung Und Infektionsbiologie E V Hans Knoell Inst | Nowe pochodne benzotiazynonu i ich zastosowanie jako środków przeciwbakteryjnych |
| EP2020406A1 (en) * | 2007-07-16 | 2009-02-04 | Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e.V. Hans-Knöll-Institut | New antimicrobial compounds, their synthesis and their use for treatment of mammalian infection |
| WO2009100731A1 (en) | 2008-02-13 | 2009-08-20 | Universita' Degli Studi Di Pavia | An effective new drug target for the treatment of tuberculosis |
| EP2380886A1 (en) | 2010-04-23 | 2011-10-26 | Vadim A. Makarov | Process for the preparation of 2-aminosubstituted 1,3-benzothiazine-4-ones |
| CN107011287A (zh) * | 2010-11-19 | 2017-08-04 | 洛桑联邦理工学院(Epfl) | 2‑哌嗪‑1‑基‑4h‑1,3‑苯并噻嗪‑4‑酮衍生物及其用于治疗哺乳动物感染的用途 |
| EP2468746A1 (en) | 2010-12-23 | 2012-06-27 | The University of Queensland | Benzothiazinone compounds and their use as anti-tuberculosis agents |
| US8486717B2 (en) | 2011-01-18 | 2013-07-16 | Symbolics, Llc | Lateral flow assays using two dimensional features |
| CN102276598B (zh) * | 2011-05-27 | 2014-11-05 | 四川大学 | 苯并噻嗪硫酮衍生物及其制备方法和用途 |
| CN102367239B (zh) * | 2011-07-20 | 2015-10-28 | 沈阳药科大学 | 2-芳基-2,3-二氢-4h-1,3-苯并噻嗪-4-酮衍生物及其用途 |
| EP2570413A1 (en) | 2011-09-15 | 2013-03-20 | The University Of Queensland | Benzothiazinone derivatives as anti-tuberculosis agents |
| CN103508980B (zh) * | 2012-06-14 | 2016-07-06 | 四川大学 | 苯并噻嗪-4-酮衍生物及其制备方法和用途 |
| US9874556B2 (en) | 2012-07-18 | 2018-01-23 | Symbolics, Llc | Lateral flow assays using two dimensional features |
| CN104211708B (zh) * | 2013-05-29 | 2018-08-24 | 中国医学科学院药物研究所 | 苯并噁嗪酮衍生物及其作为抗菌剂的应用 |
| CN108051590B (zh) | 2013-09-13 | 2020-12-11 | Symbolics有限责任公司 | 运用二维试验和对照信号读出模式的侧向层析检测 |
| MY179376A (en) | 2013-11-18 | 2020-11-05 | Basf Se | Novel initiator for preparing alkanesulfonic acids from alkane and oleum |
| DE102014012546A1 (de) * | 2014-09-26 | 2016-03-31 | Martin-Luther-Universität Halle-Wittenberg | Antimykobakteriell wirksame Substanzen, Verfahren zu ihrer Herstellung und deren Verwendung |
| EP3072889A1 (en) | 2015-03-23 | 2016-09-28 | Ecole Polytechnique Federale De Lausanne (Epfl) | 2-Homopiperazine-1-yl-4H-1,3-benzothiazine-4-one derivatives and process for the preparation of 2-(homo)piperazine 1,3-benzothiazine-4-one hydrochlorides |
| CN105622596B (zh) * | 2016-02-19 | 2018-10-30 | 浙江司太立制药股份有限公司 | 含有烷氧亚胺基氮杂环片段的苯并噻嗪-4-酮类化合物及其制备方法 |
| CN105669664B (zh) * | 2016-02-19 | 2019-05-10 | 浙江司太立制药股份有限公司 | 含有碱性氮杂环片段的苯并噻嗪-4-酮类化合物及其制备方法 |
| RU2752568C2 (ru) * | 2016-09-22 | 2021-07-29 | Ляйбниц-Институт Фюр Натурштофф-Форшунг Унд Инфекционсбиологи Е.Ф. Ханс-Кнёлль Институт (Хки) | Новые антимикробные соединения, их применение для лечения инфекций млекопитающих и новый метаболический механизм |
| RU2663848C1 (ru) * | 2018-03-23 | 2018-08-10 | Федеральное государственное бюджетное учреждение науки Институт органического синтеза им. И.Я. Постовского Уральского отделения Российской академии наук (ИОС УрО РАН) | 5-Фтор-2-(4-этоксикарбонилпиперазин-1-ил)-1,3-бензотиазин-4-он, обладающий противотуберкулезной активностью |
| CN111269197A (zh) * | 2020-04-08 | 2020-06-12 | 苏州大学 | 苯并噻嗪酮化合物及其制备方法与作为抗结核药物的应用 |
| CN113121521B (zh) * | 2021-03-26 | 2022-11-04 | 苏州大学 | 6-位三氟甲基取代的苯并噻嗪酮衍生物及其制备方法与应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3470168A (en) * | 1967-03-31 | 1969-09-30 | American Home Prod | 2-substituted-4h-1,3-benzothiazin-4-one derivatives |
| US3522247A (en) * | 1967-11-07 | 1970-07-28 | Pfizer & Co C | 2-amino-6,7-disubstituted-4h-1,3-benzothiazine-4-ones as bronchodilators |
| GB8611617D0 (en) | 1986-05-13 | 1986-06-18 | Shell Int Research | Fungicides |
| WO2000051992A1 (en) | 1999-03-04 | 2000-09-08 | E.I. Du Pont De Nemours And Company | Fused bicyclic oxazinone and thiazinone fungicides |
| EP1312607A1 (en) | 2001-11-17 | 2003-05-21 | MEDAC GmbH | Dithiocarbamate derivatives and their use as antibacterial agents |
| US7659267B2 (en) | 2002-12-05 | 2010-02-09 | Takeda Pharmaceutical Company Limited | 1,3-Benzothiazinone derivatives, process for producing the same use thereof |
| EP1732907A1 (en) * | 2004-03-26 | 2006-12-20 | Arpida A/S | Peptide deformylase inhibitors |
| PL2029583T3 (pl) | 2006-05-24 | 2010-10-29 | Leibniz Inst Fuer Naturstoff Forschung Und Infektionsbiologie E V Hans Knoell Inst | Nowe pochodne benzotiazynonu i ich zastosowanie jako środków przeciwbakteryjnych |
-
2006
- 2006-05-24 PL PL06743049T patent/PL2029583T3/pl unknown
- 2006-05-24 WO PCT/EP2006/004942 patent/WO2007134625A1/en not_active Ceased
- 2006-05-24 AU AU2006343832A patent/AU2006343832B2/en not_active Ceased
- 2006-05-24 DK DK06743049.6T patent/DK2029583T3/da active
- 2006-05-24 EA EA200870564A patent/EA015910B1/ru not_active IP Right Cessation
- 2006-05-24 CN CN2006800551120A patent/CN101472922B/zh active Active
- 2006-05-24 DE DE602006014885T patent/DE602006014885D1/de active Active
- 2006-05-24 PT PT06743049T patent/PT2029583E/pt unknown
- 2006-05-24 US US12/227,655 patent/US7863268B2/en active Active
- 2006-05-24 AT AT06743049T patent/ATE470667T1/de active
- 2006-05-24 ES ES06743049T patent/ES2345902T3/es active Active
- 2006-05-24 AP AP2008004723A patent/AP2444A/xx active
- 2006-05-24 SI SI200630745T patent/SI2029583T1/sl unknown
- 2006-05-24 EP EP06743049A patent/EP2029583B1/en active Active
- 2006-05-24 JP JP2009511341A patent/JP5068813B2/ja active Active
- 2006-05-24 CA CA2652841A patent/CA2652841C/en not_active Expired - Fee Related
- 2006-05-24 BR BRPI0621693A patent/BRPI0621693B8/pt active IP Right Grant
- 2006-05-24 MX MX2008014958A patent/MX2008014958A/es active IP Right Grant
- 2006-05-24 KR KR1020087031308A patent/KR101314999B1/ko active Active
- 2006-05-24 NZ NZ573833A patent/NZ573833A/en not_active IP Right Cessation
-
2008
- 2008-11-21 TN TNP2008000474A patent/TNSN08474A1/en unknown
- 2008-11-23 IL IL195453A patent/IL195453A/en active IP Right Grant
- 2008-12-17 CR CR10519A patent/CR10519A/es unknown
-
2010
- 2010-09-07 CY CY20101100815T patent/CY1110769T1/el unknown
- 2010-12-22 US US12/976,905 patent/US20110160193A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL195453A0 (en) | New benzothiazinone derivatives and their use as antibacterial agents | |
| TWI561237B (en) | Substituted dihydropyrazolones and their use | |
| GB0612428D0 (en) | Antibacterial agents | |
| IL184844A0 (en) | ??-cyclodextrin derivatives as antibacterial agents | |
| IL187904A0 (en) | Quinoline derivatives as antibacterial agents | |
| PT2853293T (pt) | Compostos de tionínio e a sua utilização | |
| EP2007377A4 (en) | ANTIBACTERIAL ACTIVE SUBSTANCES | |
| ZA200807809B (en) | Substituted chromanol derivatives and their use | |
| IL194880A0 (en) | Aminothiazole derivatives and their uses as antibacterial agents | |
| AP2654A (en) | Quinoline derivatives as antibacterial agents | |
| ZA200808035B (en) | Antibacterial agents | |
| IL188395A0 (en) | Quinoline derivatives as antibacterial agents | |
| GB0611115D0 (en) | Compounds and their use | |
| IL188393A0 (en) | Quinoline derivatives as antibacterial agents | |
| IL188394A0 (en) | Quinoline derivatives as antibacterial agents | |
| AP2483A (en) | Quinoline derivatives as antibacterial agents | |
| GB0619611D0 (en) | Compounds and their use | |
| ZA200810642B (en) | New benzothiazinone derivatives and their use as antibacterial agents | |
| HK1143137A (en) | 3-spiropyrimidinetrione-quinoline derivatives and their use as antibacterial agents | |
| HUP0600122A3 (en) | New compounds and their use | |
| HK1139131A (en) | 2-quinolinone and 2-quinoxalinone-derivatives and their use as antibacterial agents | |
| GB0623070D0 (en) | Antibacterial agents | |
| GB0608846D0 (en) | Compounds and their use | |
| GB0603376D0 (en) | Compounds and their use | |
| GB0610888D0 (en) | Compounds and their use |